Strategy
Integra LifeSciences Cuts 2026 Guidance After Cincinnati Flooding, With Full Manufacturing Not Back Until Q2 2027
The company put the third-quarter revenue hit at about $7 million and guided to a fourth-quarter impact of $15 million to $20 million, trimming full-year revenue and adjusted earnings outlooks.
AF
By Anna Ferreira
Oct 3, 2026 · 2 min read
Integra LifeSciences lowered its full-year 2026 outlook before Friday's open, citing a flooding-related supply disruption at its Cincinnati facility that the company does not expect to resolve until the second quarter of next year.
Discussion (0)
Sign in to join the discussion.
Loading comments…
AF
Anna Ferreira
Senior Correspondent, Corporate Strategy
Anna Ferreira writes for Corporate Insider Inc.